Utilisation of primary care electronic patient records for identification and targeted invitation of individuals to a lung cancer screening programme.


Journal

Lung cancer (Amsterdam, Netherlands)
ISSN: 1872-8332
Titre abrégé: Lung Cancer
Pays: Ireland
ID NLM: 8800805

Informations de publication

Date de publication:
11 2022
Historique:
received: 09 05 2022
revised: 27 07 2022
accepted: 13 09 2022
pubmed: 1 10 2022
medline: 21 10 2022
entrez: 30 9 2022
Statut: ppublish

Résumé

Lung cancer screening (LCS) eligibility is largely determined by tobacco consumption. Primary care smoking data could guide LCS invitation and eligibility assessment. We present observational data from the SUMMIT Study, where individual self-reported smoking status was concordant with primary care records in 75.3%. However, 10.3% demonstrated inconsistencies between historic and most recent smoking status documentation. Quantified tobacco consumption was frequently missing, precluding direct LCS eligibility assessment. Primary care recorded "ever-smoker" status, encompassing both recent and historic documentation, can be used to target LCS invitation. Identifying those with missing or erroneous "never-smoker" smoking status is crucial for equitable invitation to LCS.

Identifiants

pubmed: 36179541
pii: S0169-5002(22)00635-3
doi: 10.1016/j.lungcan.2022.09.009
pmc: PMC10533413
mid: EMS188588
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

94-100

Subventions

Organisme : Wellcome Trust
ID : WT107963AIA
Pays : United Kingdom
Organisme : Cancer Research UK
ID : EDDCPGM/100002
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 28706
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 209553
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 24460
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T02481X/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C50664/A24460
Pays : United Kingdom

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
BMJ Open. 2020 Sep 10;10(9):e037075
pubmed: 32912947
Ann Intern Med. 2014 Mar 4;160(5):330-8
pubmed: 24378917
Thorax. 2022 Oct;77(10):1036-1040
pubmed: 35863766
J Natl Cancer Inst. 2011 Jul 6;103(13):1058-68
pubmed: 21606442
Thorax. 2022 Sep;77(9):882-890
pubmed: 34716280
Am J Respir Crit Care Med. 2020 Apr 15;201(8):965-975
pubmed: 31825647
Addiction. 2007 May;102(5):803-8
pubmed: 17506157
N Engl J Med. 2020 Feb 6;382(6):503-513
pubmed: 31995683
J Public Health Med. 2000 Jun;22(2):198-201
pubmed: 10912559
Thorax. 2019 Apr;74(4):405-409
pubmed: 29440588
Br J Cancer. 2021 Jun;124(12):2026-2034
pubmed: 33846525
Lung Cancer. 2020 Oct;148:12-19
pubmed: 32771715

Auteurs

Jennifer L Dickson (JL)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.

Helen Hall (H)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.

Carolyn Horst (C)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.

Sophie Tisi (S)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.

Priyam Verghese (P)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.

Sarah Worboys (S)

James Wigg GP Practice, London, UK.

Andrew Perugia (A)

NOCLOR Research Support, London, UK.

James Rusius (J)

NOCLOR Research Support, London, UK.

Anne-Marie Mullin (AM)

Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.

Jonathan Teague (J)

Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.

Laura Farrelly (L)

Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.

Vicky Bowyer (V)

University College London Hospitals NHS Foundation Trust, London, UK.

Kylie Gyertson (K)

University College London Hospitals NHS Foundation Trust, London, UK.

Fanta Bojang (F)

University College London Hospitals NHS Foundation Trust, London, UK.

Claire Levermore (C)

University College London Hospitals NHS Foundation Trust, London, UK.

Tania Anastasiadis (T)

Tower Hamlets Clinical Commissioning Group, London, UK.

John McCabe (J)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.

Anand Devaraj (A)

Department of Radiology, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College, London, UK.

Arjun Nair (A)

University College London Hospitals NHS Foundation Trust, London, UK.

Neal Navani (N)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK; University College London Hospitals NHS Foundation Trust, London, UK.

Allan Hackshaw (A)

Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.

Samantha L Quaife (SL)

Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Sam M Janes (SM)

Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK; University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: s.janes@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH